Search for: "Lange v. Andrews" Results 101 - 120 of 127
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2023, 9:22 am by Miquel Montañá (Clifford Chance)
In this regard, in its judgment of 12 December 2013 (case C-493/12, Eli Lilly v Human Genome Sciences), the CJEU made the following observations: “30. [read post]
As an example, it can be a sign of infringement if the marketing strategy induces doctors to prescribe the generic for the omitted therapeutic indication (GlaxoSmithKline v. [read post]
21 Dec 2009, 3:06 am
Miller (Lewis and Clark), Judith V. [read post]
In an earlier post I explained the issues that the proposed EU Regulation on SEPs intends to address, and why neither the market nor the courts solve them. [read post]
2 Jul 2013, 1:41 pm
Strangelove" (16) "Flight of the Conchords" (4) "Game Change" (2) "Get Smart" (1) "Gran Torino" (10) "Grey Gardens" (13) "I Shouldn't Be Alive" (4) "Limelight" (3) "Meet the Press" (20) "Moby Dick" (5) "My Dinner with Andre" (34) "Mystery Science Theater" (2) "Project Runway" (78) "Romy and Michele's High School Reunion" (3) "Seinfeld" (72) "Sex and the City" (14) "Slacker" (11) "Slumdog Millionaire" (16) "SNL" (60) "Sopranos" (50) "South Park" (71) "Star Trek" (12) "Star Wars" (25) "Survivor" (50)… [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
Or that the credibility of the technical effect is assessed at the priority or filing date (e.g., TGI Paris, October 6, 2009, RG n°07/16446, Teva v. [read post]
It is superfluous for cases such as Ericsson v Apple, costly and lengthy for the litigants, and clogs the court system. [read post]
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 [read post]
13 Feb 2024, 1:33 am by Kluwer Patent blogger
’ More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Artificial Intelligence and Patents: An International Perspective on Patenting AI-Related Inventions by Jonathan P. [read post]
22 May 2012, 5:38 am by INFORRM
This has been a challenging year for the media in Australia, with traditional business models thrown into turmoil by new media platforms. [read post]
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
5 Oct 2006, 12:23 am
Serbia and Montenegro) Case Resources Pulp Mills on the River Uruguay (Argentina v. [read post]
22 Oct 2012, 3:21 am by New Books Script
K 4550 T39 2012 Tax treaty case law around the globe : 2011 / edited by Michael Lang … [et al.] [read post]
4 Apr 2012, 6:39 am by Rob Robinson
§1920 – bit.ly/HewRoz (Mark Sidoti) PhotoCop & The Red Light of Admissibility - bit.ly/H18QVF (Josh Gilliland) Pippins v. [read post]
18 Jul 2012, 5:57 am by Rob Robinson
  http://bit.ly/MGu5uA (Andrew Bartholomew) Legal Technology Observer Concludes Today, Inviting You to Continue the Conversation - http://bit.ly/LRn3EO (Christy Burke) Making Sense of ‘Kleen Products’: Is it Really about Predictive Coding? [read post]